Current Good Manufacturing Practice (CGMP); Quality System (QS) Regulation

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
HIV Proposed Reclassification Feb 21 2020.pdf	Supplementary Document	Uploaded 2021-02-26	Repair queued
0073 Change Request for HIV device Feb 2021.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2021-02-26	Missing upstream
0073_Supporting Statement_2019.doc	Supporting Statement A	Uploaded 2019-11-15	Repair queued

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
5715	Current Good Manufacturing Practice (CGMP); Quality System (QS) Regulation		Unchanged

ICR Details

OMB Control No: 0910-0073	ICR Reference No: 202102-0910-005
Status: Received in OIRA	Previous ICR Reference No: 201911-0910-004
Agency/Subagency: HHS/FDA	Agency Tracking No: CDRH
Title: Current Good Manufacturing Practice (CGMP); Quality System (QS) Regulation
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 02/26/2021

table that charts list comparision

	Requested	Previously Approved
Expiration Date	12/31/2022	12/31/2022
Responses	27,074	27,074
Time Burden (Hours)	9,021,752	9,021,752
Cost Burden (Dollars)	0	0

---

Abstract: This ICR collects information from medical device manufacturers who must meet the Current Good Manufacturing Practice Quality System (CGMP/QS) requirements for purchasing and service controls; recordkeeping requirements for device failure and complaint investigations; requirements for verifying/validating production processes and process or product changes; and requirements for product acceptance activities, quality data evaluations, and corrections of nonconforming product/quality problems. CGMP/QS information collections assist FDA inspections of manufacturer compliance with quality system requirements encompassing design, production, installation, and servicing processes. Manufacturers must ensure that medical devices meet design specifications and that design specifications are effectively transferred from research and development to production.

---

Authorizing Statute(s): US Code: 21 USC 374 Name of Law: Federal Food, Drug, and Cosmetic Act
   US Code: 21 USC 381 Name of Law: Federal Food, Drug, and Cosmetic Act
   US Code: 21 USC 384 Name of Law: Federal Food, Drug, and Cosmetic Act
   US Code: 21 USC 360 Name of Law: Federal Food, Drug, and Cosmetic Act
   US Code: 21 USC 371 Name of Law: Federal Food, Drug, and Cosmetic Act
   US Code: 21 USC 351 Name of Law: Federal Food, Drug, and Cosmetic Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 37317	07/31/2019
30-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 62534	11/15/2019
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Current Good Manufacturing Practice (CGMP); Quality System (QS) Regulation

---

ICR Summary of Burden

table that charts list of burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	27,074	27,074	0	0	0	0
Annual Time Burden (Hours)	9,021,752	9,021,752	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: We have adjusted the number of respondents based on updated Registration and Listing data for FY2019 (previously 24,738 respondents per IC; updated to 27,074 respondents per IC). This caused a 412,928-hour increase in the total estimated burden. There are no program changes.

---

Annual Cost to Federal Government: $51,357,950

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 02/26/2021

---